The New England Journal of Medicine, ISSN 0028-4793, 10/2012, Volume 367, Issue 14, pp. 1297 - 1309
This trial compared the efficacy of antiplatelet therapy with prasugrel or clopidogrel in patients with non–ST-segment elevation MI or unstable angina....
MEDICINE, GENERAL & INTERNAL | OUTCOMES | MYOCARDIAL-INFARCTION | MEDICAL-MANAGEMENT | PREDICTORS | STRATEGY | Prasugrel Hydrochloride | Thiophenes - therapeutic use | Myocardial Infarction - epidemiology | Follow-Up Studies | Thiophenes - adverse effects | Ticlopidine - therapeutic use | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Angina, Unstable - drug therapy | Ticlopidine - adverse effects | Cardiovascular Diseases - mortality | Female | Stroke - epidemiology | Aspirin - therapeutic use | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Double-Blind Method | Kaplan-Meier Estimate | Purinergic P2 Receptor Antagonists - therapeutic use | Piperazines - therapeutic use | Piperazines - adverse effects | Ticlopidine - analogs & derivatives | Purinergic P2 Receptor Antagonists - adverse effects | Acute Coronary Syndrome - drug therapy | Myocardial Infarction - drug therapy | Aged | Myocardial infarction | Cerebral infarction | Aspirin | Heart attacks | Medical imaging | Angina | Angina pectoris | Patients | Bleeding | Ischemia | Patient safety | Clopidogrel | Acute coronary syndromes | Heart diseases | Age
MEDICINE, GENERAL & INTERNAL | OUTCOMES | MYOCARDIAL-INFARCTION | MEDICAL-MANAGEMENT | PREDICTORS | STRATEGY | Prasugrel Hydrochloride | Thiophenes - therapeutic use | Myocardial Infarction - epidemiology | Follow-Up Studies | Thiophenes - adverse effects | Ticlopidine - therapeutic use | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Angina, Unstable - drug therapy | Ticlopidine - adverse effects | Cardiovascular Diseases - mortality | Female | Stroke - epidemiology | Aspirin - therapeutic use | Drug Therapy, Combination | Platelet Aggregation Inhibitors - therapeutic use | Platelet Aggregation Inhibitors - adverse effects | Double-Blind Method | Kaplan-Meier Estimate | Purinergic P2 Receptor Antagonists - therapeutic use | Piperazines - therapeutic use | Piperazines - adverse effects | Ticlopidine - analogs & derivatives | Purinergic P2 Receptor Antagonists - adverse effects | Acute Coronary Syndrome - drug therapy | Myocardial Infarction - drug therapy | Aged | Myocardial infarction | Cerebral infarction | Aspirin | Heart attacks | Medical imaging | Angina | Angina pectoris | Patients | Bleeding | Ischemia | Patient safety | Clopidogrel | Acute coronary syndromes | Heart diseases | Age
Journal Article
Nuclear Fusion, ISSN 0029-5515, 2015, Volume 55, Issue 10, pp. 1 - 14
Since the installation of an ITER-like wall, the JET programme has focused on the consolidation of ITER design choices and the preparation for ITER operation,...
FUEL RETENTION | CARBON | PHYSICS, FLUIDS & PLASMAS | EROSION | tokamaks | ITER-LIKE WALL | TRANSPORT | DIVERTOR | PLASMA-FACING COMPONENTS | OPERATION | JET | TUNGSTEN | magnetic confinement | Nucleation | Tungsten | Materials selection | Carbon | Walls | Deposition | Erosion | Melts | 70 PLASMA PHYSICS AND FUSION TECHNOLOGY | Fysik | Physical Sciences | Subatomic Physics | Naturvetenskap | Subatomär fysik | Natural Sciences
FUEL RETENTION | CARBON | PHYSICS, FLUIDS & PLASMAS | EROSION | tokamaks | ITER-LIKE WALL | TRANSPORT | DIVERTOR | PLASMA-FACING COMPONENTS | OPERATION | JET | TUNGSTEN | magnetic confinement | Nucleation | Tungsten | Materials selection | Carbon | Walls | Deposition | Erosion | Melts | 70 PLASMA PHYSICS AND FUSION TECHNOLOGY | Fysik | Physical Sciences | Subatomic Physics | Naturvetenskap | Subatomär fysik | Natural Sciences
Journal Article
Nuclear Fusion, ISSN 0029-5515, 10/2013, Volume 53, Issue 10, pp. 104002 - 19
Following the completion in May 2011 of the shutdown for the installation of the beryllium wall and the tungsten divertor, the first set of JET campaigns have...
DIVERTOR | PLASMA-FACING COMPONENTS | PHYSICS, FLUIDS & PLASMAS | PERFORMANCE | REGIME | TUNGSTEN | PHYSICS, NUCLEAR | TOKAMAK PLASMAS | Confinement | Impurities | Restoration | Disruption | Plasmas | Gas injection | Carbon | Walls | Fusion, Plasma and Space Physics | Fysik | Fusion, plasma och rymdfysik | Physical Sciences | Naturvetenskap | Natural Sciences
DIVERTOR | PLASMA-FACING COMPONENTS | PHYSICS, FLUIDS & PLASMAS | PERFORMANCE | REGIME | TUNGSTEN | PHYSICS, NUCLEAR | TOKAMAK PLASMAS | Confinement | Impurities | Restoration | Disruption | Plasmas | Gas injection | Carbon | Walls | Fusion, Plasma and Space Physics | Fysik | Fusion, plasma och rymdfysik | Physical Sciences | Naturvetenskap | Natural Sciences
Journal Article
Fusion Engineering and Design, ISSN 0920-3796, 05/2016, Volume 106, pp. 9 - 16
Engineering and technical constraints on Neutral Beam Injection (NBI) in DEMO may determine the available beam energy and may also strongly impact the Neutral...
Neutral beam | DEMO | Genetic algorithm
Neutral beam | DEMO | Genetic algorithm
Journal Article
Nuclear Fusion, ISSN 0029-5515, 01/2018, Volume 58, Issue 1
Journal Article
Nuclear Fusion, ISSN 0029-5515, 06/2017, Volume 57, Issue 10, p. 102001
The 2014-2016 JET results are reviewed in the light of their significance for optimising the ITER research plan for the active and non-active operation. More...
fusion | JET | ITER | plasma | COLLISIONALITY | DISRUPTION PREDICTION | ELMY H-MODES | PHYSICS, FLUIDS & PLASMAS | PEDESTAL | PLASMA-FACING COMPONENTS | OPERATION | CARBON WALL | DENSITY PEAKING | EDGE LOCALIZED MODES | DIAGNOSTICS | Mechanics | Engineering Sciences | Fluids mechanics | 70 PLASMA PHYSICS AND FUSION TECHNOLOGY | Fusion, Plasma and Space Physics | Fysik | Fusion, plasma och rymdfysik | Physical Sciences | Naturvetenskap | Natural Sciences
fusion | JET | ITER | plasma | COLLISIONALITY | DISRUPTION PREDICTION | ELMY H-MODES | PHYSICS, FLUIDS & PLASMAS | PEDESTAL | PLASMA-FACING COMPONENTS | OPERATION | CARBON WALL | DENSITY PEAKING | EDGE LOCALIZED MODES | DIAGNOSTICS | Mechanics | Engineering Sciences | Fluids mechanics | 70 PLASMA PHYSICS AND FUSION TECHNOLOGY | Fusion, Plasma and Space Physics | Fysik | Fusion, plasma och rymdfysik | Physical Sciences | Naturvetenskap | Natural Sciences
Journal Article
NUCLEAR FUSION, ISSN 0029-5515, 01/2018, Volume 58, Issue 1, p. 16028
Experiments have been carried out on the MAST and JET tokamaks intended to compare the electrical resistivity of the plasma with theoretical formulations. The...
diffusion | PROFILES | PHYSICS, FLUIDS & PLASMAS | classical | ARBITRARY COLLISIONALITY | DISCHARGES | DENSITY | BOOTSTRAP CURRENT | ENERGY CONFINEMENT | TRANSPORT | H-MODE | stationary-state plasmas | DRIVEN CURRENTS | plasma resistivity | neoclassical resistivity | TOKAMAK
diffusion | PROFILES | PHYSICS, FLUIDS & PLASMAS | classical | ARBITRARY COLLISIONALITY | DISCHARGES | DENSITY | BOOTSTRAP CURRENT | ENERGY CONFINEMENT | TRANSPORT | H-MODE | stationary-state plasmas | DRIVEN CURRENTS | plasma resistivity | neoclassical resistivity | TOKAMAK
Journal Article
Nuclear Fusion, ISSN 0029-5515, 06/2017, Volume 57, Issue 10, p. 102011
The TCV tokamak is augmenting its unique historical capabilities (strong shaping, strong electron heating) with ion heating, additional electron heating...
tokamak | overview | TCV | TRANSPORT | PHYSICS, FLUIDS & PLASMAS | Plasma Physics | Physics | Controllers | Magnetoplasma | Cyclotron resonance | Electron cyclotron resonance | Fysik | Plasma simulation | Natural Sciences | Fundamental research | Plasma heating | Neoclassical tearing modes | Scientific progress | Particle beams | Sols | Electric discharges | Tokamak devices | Cyclotrons | Physical Sciences | Naturvetenskap | Scenario development | Heating | Neutral beam injectors (NBI) | Nuclear reactors | Electrons | Electron cyclotron resonance heating
tokamak | overview | TCV | TRANSPORT | PHYSICS, FLUIDS & PLASMAS | Plasma Physics | Physics | Controllers | Magnetoplasma | Cyclotron resonance | Electron cyclotron resonance | Fysik | Plasma simulation | Natural Sciences | Fundamental research | Plasma heating | Neoclassical tearing modes | Scientific progress | Particle beams | Sols | Electric discharges | Tokamak devices | Cyclotrons | Physical Sciences | Naturvetenskap | Scenario development | Heating | Neutral beam injectors (NBI) | Nuclear reactors | Electrons | Electron cyclotron resonance heating
Journal Article
The Lancet, ISSN 0140-6736, 09/2003, Volume 362, Issue 9386, pp. 782 - 788
Treatment with angiotensin-converting-enzyme (ACE) inhibitors reduces the rate of cardiovascular events among patients with left-ventricular dysfunction and...
SURVIVAL | MEDICINE, GENERAL & INTERNAL | ACE | LEFT-VENTRICULAR DYSFUNCTION | MYOCARDIAL-INFARCTION | HYPERTENSION | EXPRESSION | CONVERTING-ENZYME-INHIBITORS | BLOOD-PRESSURE | CAPTOPRIL | Double-Blind Method | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Treatment Outcome | Cause of Death | Coronary Disease - mortality | Heart Failure - prevention & control | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Heart Arrest - prevention & control | Cardiovascular Diseases - mortality | Coronary Disease - drug therapy | Female | Myocardial Infarction - prevention & control | Perindopril - therapeutic use | Evaluation | Drug therapy | ACE inhibitors | Coronary heart disease | Cardiovascular agents | Cardiovascular disease | Heart attacks | Medical treatment | Morbidity | Clinical outcomes | Myocardial infarction | Risk | Subgroups | Reduction | Motivation | Peptidyl-dipeptidase A | Gangrene | Cardiology | Heart diseases | Heart failure | Hypertension | Stroke | Risk groups | Mortality | Coronary artery | Health risks | Risk reduction | Angina pectoris | Coronary artery disease | Disease control | Patients | Heart rate | Inhibitors | Coronary vessels | Angiotensin | Infarction | Diabetes | Ventricle | Cardiovascular diseases | Health risk assessment | Potassium
SURVIVAL | MEDICINE, GENERAL & INTERNAL | ACE | LEFT-VENTRICULAR DYSFUNCTION | MYOCARDIAL-INFARCTION | HYPERTENSION | EXPRESSION | CONVERTING-ENZYME-INHIBITORS | BLOOD-PRESSURE | CAPTOPRIL | Double-Blind Method | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Treatment Outcome | Cause of Death | Coronary Disease - mortality | Heart Failure - prevention & control | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Heart Arrest - prevention & control | Cardiovascular Diseases - mortality | Coronary Disease - drug therapy | Female | Myocardial Infarction - prevention & control | Perindopril - therapeutic use | Evaluation | Drug therapy | ACE inhibitors | Coronary heart disease | Cardiovascular agents | Cardiovascular disease | Heart attacks | Medical treatment | Morbidity | Clinical outcomes | Myocardial infarction | Risk | Subgroups | Reduction | Motivation | Peptidyl-dipeptidase A | Gangrene | Cardiology | Heart diseases | Heart failure | Hypertension | Stroke | Risk groups | Mortality | Coronary artery | Health risks | Risk reduction | Angina pectoris | Coronary artery disease | Disease control | Patients | Heart rate | Inhibitors | Coronary vessels | Angiotensin | Infarction | Diabetes | Ventricle | Cardiovascular diseases | Health risk assessment | Potassium
Journal Article